Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/10242
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKarimov Murodullo Yuldashevich, Yakubjanov Ravshan Rahimjanovich, Ismoilov Nurhon Uralovich, Mamajonov Shavkat Toxirovich, Qobilov Nodir Rustamovich-
dc.date.accessioned2024-01-15T19:32:53Z-
dc.date.available2024-01-15T19:32:53Z-
dc.date.issued2023-10-26-
dc.identifier.issn2091–5853-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/10242-
dc.description.abstractRelevance. Anterior cruciate ligament (ACL) inju ries are common in athletes and can lead to significant functional limitations and long-term disability if not properly treated. Objective: The efficacy of tenoxicam in patients un dergoing anterior cruciate ligament reconstruction in the early rehabilitation period was investigated in this scientific paper. Material and research methods. This study was a retro-prospective, single center study of the clinical effi cacy and safety of tenoxicam in early rehabilitation after anterior cruciate ligament (ACL) reconstruction. Results. The results revealed a significant reduction in pain and improved functional activities among pa tients using tenoxicam, compared to the control group. Conclusion. This study has shown that tenoxicam can help improve rehabilitation outcomes by reducing pain and inflammation, improving range of motion, and increasing muscle strengthen_US
dc.publisherАкадемия наук Республики Узбекистанen_US
dc.subjectолдинги хочсимон бойлам, оғриқ қолдирувчи дори воситалар, реабилитация.en_US
dc.title"Оценка эффектив- ности антиалгических препаратов после восстанов- ления передней крестообразной связки"en_US
dc.title.alternative“Журнал теоретической и клинической медицины”, №4en_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
махаллий макола 2023 .pdf12 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.